Search

A convenient protocol for the synthesis of thiazole‐2‐thiones from nitrobenzene, chalcones and carbon disulfide is described. The construction of one C−S bond and two C−N bonds via [3+2] cycloaddition reaction is achieved using NaOH as the base in one pot. Various functional groups attached to substrates were well tolerated to afford the corresponding products in moderate to good yields. [ABSTRACT FROM AUTHOR]

• HSP90 inhibitors 17-AAG and VER-82576 inhibit porcine deltacoronavirus replication at the early stage of infection. • HSP90 inhibitor KW-2478 shows no significant antiviral activity at any stage of infection. • 17-AAG and VER-82576 inhibit the expressions of TNF-α, IL-6 and IL-12, which are PDCoV-induced proinflammatory cytokines. • Our findings conclude that 17-AAG and VER-82576 are promising candidates for the treatment of PDCoV infection. Porcine deltacoronavirus (PDCoV) is highly pathogenic to piglets, and no specific drugs or vaccines are available for the prevention and treatment of PDCoV infection, the need for antiviral therapies is pressing. HSP90 inhibitors have potent inhibitory effects against the replication of numerous viruses, hence we evaluated three HSP90 inhibitors, 17-AAG, VER-82576, and KW-2478, for their effects on PDCoV infection in vitro. We evaluated their effectivenesses at suppressing PDCoV by qRT-PCR, western blot, and TCID 50 assay, and found that 17-AAG and VER-82576 inhibited PDCoV at the early stage of replication, while KW-2478 showed no significant antiviral activity at any stage of infection. These results indicated that the PDCoV-inhibitory effects of 17-AAG and VER-82576 might be exerted by targeting host cell factor HSP90AB1 but not HSP90AA1. Further study showed that HSP90AB1 mRNA and protein levels were not significantly different in 17-AAG and VER-82576-treated cells versus control cells. 17-AAG and VER-82576 were also evaluated for their effects on the expressions of TNF-α, IL-6, and IL-12, which are PDCoV-induced proinflammatory cytokines. We found that both 17-AAG and VER-82576 inhibited the expressions of TNF-α, IL-6, and IL-12 to varying degrees, but in a dose dependent manner. From our data we can conclude that the HSP90 inhibitors 17-AAG and VER-82576 are promising candidates for the treatment of PDCoV infection. [ABSTRACT FROM AUTHOR]